Bulimia Nervosa Clinical Trial
— FaciBOfficial title:
Identification of Decision Making Processes in Food, Risky and Steal Situations in Bulimia Nervosa
Verified date | September 2021 |
Source | Hôpital le Vinatier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This trial is a set of four independent experiments involving for each of them functional and structural MRI data acquisition. They aim at investigating decision making mechanisms in bulimia nervosa when participants have to make food or monetary choices under specific conditions that mimic binge eating episodes or kleptomania which are two major symptoms of bulimia nervosa. All experiments are cross sectional studies. Each experiment is subdivided into two parts: a first part without any MRI data acquisition and during which all the tasks are performed. This part aims at making sure that a behavioral effect is observed before starting MRI data acquisition. The second part aims at investigating the neural correlates observed in the first part and additionally, at reproducing the behavioral effects observed in the first part. Therefore the first part may be regarded as an independent study as compared to the second part.
Status | Terminated |
Enrollment | 59 |
Est. completion date | June 15, 2021 |
Est. primary completion date | June 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - men and women aged 18 to 35 years with bulimia nervosa according to DSM 5 criteria for the patient's group - For the control group, men and women with the same age range being concerned by food intake and their body shape but without any history of eating disorder. - All participants must have signed an informed consent form and be affiliated to the French public health insurance. - for MRI scans, all participants must be right handed. Exclusion Criteria: - antisocial personality disorder, - borderline personality disorder - addiction to alcohol or psychoactive agent, ADHD, any psychotic disorder, - obesity of class 1 or 2 - istory of psychiatric disorder for the control group - history of neurological disorder for both groups - intermittent explosive disorder - any counter indication to MRI scans for the parts of experiments which take place in the MRI scanner. |
Country | Name | City | State |
---|---|---|---|
France | Hopital Vinatier | Lyon | Rhone Alpes |
Lead Sponsor | Collaborator |
---|---|
Hôpital le Vinatier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | oxygen variation in the brain | Brain activity related to task performance collected in the MRI scanner.Blood Oxygen Level Dependent response synchronized with any event of interest during the task. Events of interests are:
Onset time of any visual stimulus Onset time of any response of the participant. |
10 days | |
Secondary | Task related parameters | reaction times computed as the duration in ms between the onset time of the stimulus and the onset time of the participant's answer. Several tasks may be involved in each experiment including in the MRI scan.
These rules apply to all tasks. |
10 days | |
Secondary | Skin conductance response related to events in the task performed while the signal is being collected | Skin conductance response in microSiemens synchronized with any event of interest during the task. Events of interests are:
Onset time of any visual stimulus Onset time of any response of the participant |
10 days | |
Secondary | cardiac frequency in beats per minute related to events in the task performed while the signal is being collected | cardiac frequency is computed from the pulse plethysmogram sensor signal while the participant is performing the task. Task during which this signal is collected may be one of the tasks performed in the scanner as well as tasks performed outside the scanner. | 10 days | |
Secondary | parameters of eye movements extracted from the eye tracking signal is being collected | The parameters computed are X and Y position of the eye by amplitude of variation of pupil size over a time window synchronized with events in the task | 10 days | |
Secondary | Eating Disorders Examination (EDE-Q) | The EDE is a semi-structured interview conducted by a trained clinician to assess the psychopathology associated with the diagnosis of an eating disorder. The EDE is rated through the use of four subscales (restraint, eating concern, weight concern, shape concern) and global score. | 10 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Terminated |
NCT04278755 -
Binge Eating & Birth Control
|
Phase 2 | |
Withdrawn |
NCT02978742 -
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder
|
N/A | |
Withdrawn |
NCT00988481 -
Topiramate Augmentation in Bulimia Nervosa Partial Responders
|
Phase 4 | |
Completed |
NCT00184301 -
A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.
|
N/A | |
Completed |
NCT00522769 -
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
|
Phase 1/Phase 2 | |
Completed |
NCT00304187 -
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
|
Phase 2 | |
Recruiting |
NCT04409457 -
Self-Control in Bulimia Nervosa
|
N/A | |
Recruiting |
NCT05509257 -
Naltrexone Neuroimaging in Teens With Eating Disorders
|
Early Phase 1 | |
Recruiting |
NCT05937243 -
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
|
N/A | |
Recruiting |
NCT05862389 -
Study on the Mechanism of Eating Disorder
|
||
Recruiting |
NCT05728021 -
Smartphone-based Aftercare for Inpatients With Bulimia Nervosa
|
N/A | |
Completed |
NCT03781921 -
The Neural Bases of Emotion Regulation in Bulimia Nervosa
|
||
Completed |
NCT02553824 -
FDA Approved Medication to Reduce Binge Eating and/or Purging
|
Phase 1 | |
Completed |
NCT04265131 -
Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?
|
N/A | |
Recruiting |
NCT06431854 -
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
|
N/A | |
Recruiting |
NCT02960152 -
Periodontal Impact of Eating Disorders (the PERIOED Study)
|
N/A | |
Completed |
NCT00916071 -
Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders
|
N/A | |
Terminated |
NCT00308776 -
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
|
N/A | |
Completed |
NCT03712748 -
Online Imaginal Exposure
|
N/A |